Join
Live feed
·
NEWSReleasevia Quantisnow
Revelation Biosciences Inc. logo

Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury

ByQuantisnow·Wall Street's wire, on your screen.
REVB· Revelation Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REVB (Revelation Biosciences Inc.) and more on Quantisnow.